BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 13/03/2012

FDA Clears DURANEST Drug Products for Approval

The FDA has determined that DURANEST (etidocaine hydrochloride) injection and five other drug products were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications (ANDAs).

Source: Federal Register — Food and Drug AdministrationOpen original release →